US health providers are adamant that access to the NHS will be simpler and drug prices will increase following Brexit

The prospectus reveals that drug companies will call for new regulations to "discriminate" international suppliers and to limit the number of suppliers.

Writing last month by the American Chamber of Commerce, he noted the three-year failure to reach an agreement with the EU th...

Biocon's future focus on making processes robust and GMP compliance

As the chair at the helm of Biocon changes face, there is a new zeal to increase the efforts in making the processes more robust and to make them free from excessive human interference. The company is embarking on a digital journey from the quality control and process control point of view, which...